Clinical Trials Browser

Metastatic Castration-resistant Prostate Cancer × pamiparib × Genitourinary × Clear all

NCT05327621 2022-04-14

Pamiparib in mCRPC With HRD or BRCA1/2 Mutation

Phase 2 Unknown

Metastatic Castration-resistant Prostate Cancer